Supplementary Table 5 from Phase II Window Study of Olaparib Alone or with Cisplatin or Durvalumab in Operable Head and Neck Cancer
收藏NIAID Data Ecosystem2026-05-01 收录
下载链接：
https://figshare.com/articles/dataset/Supplementary_Table_5_from_Phase_II_Window_Study_of_Olaparib_Alone_or_with_Cisplatin_or_Durvalumab_in_Operable_Head_and_Neck_Cancer/23925600
下载链接
链接失效反馈官方服务：
资源简介：
Supplementary Table 5. Incidence of adverse events by maximum grade in the safety population.
创建时间：
2023-08-10
